Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0CT4D
|
||||
Former ID |
DCL000730
|
||||
Drug Name |
Brivaracetam
|
||||
Synonyms |
Rikelta; UCB-34714; Brivaracetam (USAN/INN)
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
UCB
|
||||
Structure |
Download2D MOL |
||||
Formula |
C11H20N2O2
|
||||
Canonical SMILES |
CCCC1CC(=O)N(C1)C(CC)C(=O)N
|
||||
InChI |
1S/C11H20N2O2/c1-3-5-8-6-10(14)13(7-8)9(4-2)11(12)15/h8-9H,3-7H2,1-2H3,(H2,12,15)/t8-,9+/m1/s1
|
||||
InChIKey |
MSYKRHVOOPPJKU-BDAKNGLRSA-N
|
||||
CAS Number |
CAS 357336-20-0
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Synaptic vesicle glycoprotein 2A | Target Info | Inhibitor | [536234], [536845] | |
KEGG Pathway | ECM-receptor interaction | ||||
References | |||||
Ref 536757 | New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channels. Curr Neurol Neurosci Rep. 2008 Jul;8(4):345-52. | ||||
Ref 536934 | Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX). Epilepsy Res. 2009 Jan;83(1):1-43. Epub 2008 Nov 12. | ||||
Ref 889440 | 2016 FDA drug approvals. Nat Rev Drug Discov. 2017 Feb 2;16(2):73-76. doi: 10.1038/nrd.2017.14. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.